Last updated: April 4, 2024
Sponsor: McGill University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Lymphoma
Treatment
Waitlist control
Lymfit exercise intervention
Clinical Study ID
NCT05257785
2021-2560
Ages 18-39 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- newly diagnosed lymphoma patients who received an initial diagnosis at the age of age 18-39,
- approved by their hematologist as having no contra-indications to vigorous exercise,
- receiving or has received chemotherapy with curative intent within the past 6 months,
- own a cellular phone that is able to download the Fitbit app and to complete the studyquestionnaires online in either French or English, and
- has an Internet connection at home that supports participation in coaching sessionsvia videoconferencing (zoom).
Exclusion
Exclusion Criteria:
- The patient has contra-indications to vigorous exercise,
- the patient doesn't want to wear a fitness tracker due to various concerns (as noFitbit data could be collected).
Study Design
Total Participants: 50
Treatment Group(s): 2
Primary Treatment: Waitlist control
Phase:
Study Start date:
January 15, 2022
Estimated Completion Date:
December 01, 2024
Study Description
Connect with a study center
Jewish General Hospital
Montreal, Quebec H3A 2A7
CanadaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.